QualityStocksNewsBreaks – Teewinot Life Sciences Lowers Production Cost of Clinical-Grade Cannabinoids with Proprietary Synthetic Biology Technology
Teewinot Life Sciences is on a mission to cut costs of cannabinoid production while approaching the process like a pharmaceutical company, not as a cannabis firm. An article discussing the company reads: “Teewinot Life Sciences is a Tampa, Florida-based global biopharmaceutical company focused on cannabinoid clinical development utilizing patented and proprietary synthetic biology and biocatalysis technology. Its strategy involves the production and use of cannabinoid molecules. The goal of the company is to produce, at lower cost, consistent and pure cannabinoids that it believes can be used to develop superior human therapies.” To view the full article, visit http://ibn.fm/8EvOn Let…